Tokyo, March 12 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060902) titled 'Impact of photoselective vaporization of the prostate (PVP-XPS) on work productivity in working-age men with benign prostatic hyperplasia requiring surgical treatment' on March 12.
Study Type:
Observational
Primary Sponsor:
Institute - Japanese Red Cross Kushiro Hospital
Condition:
Condition - Benign prostatic hyperplasia
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The aim of this study was to investigate whether photoselective vaporization of the prostate (PVP-XPS) improves work productivity in working-age men with benign prostatic hyperplasia requiring surgical treatment.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 40
years-old
<=
Age-upper limit - Not applicable
Gender - Male
Key inclusion criteria - 1.Patients with benign prostatic hyperplasia undergoing photoselective vaporization of the prostate.
2.Male patients aged 40 years or more.
3.Patients with an estimated prostate volume of 30 to 80 g.
4.Patients who provide written informed consent for participation in the study.
Key exclusion criteria - 1.Patients who are unable to speak Japanese.
2.Patients with anatomical abnormalities of the urinary tract.
3.Patients with a history of surgical intervention for benign prostatic hyperplasia.
4.Patients deemed unsuitable for the study by the attending physician.
Target Size - 50
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2026 Year 01 Month 16 Day
Date of IRB - 2026 Year 01 Month 16 Day
Anticipated trial start date - 2026 Year 01 Month 16 Day
Last follow-up date - 2029 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069695
Disclaimer: Curated by HT Syndication.
